Paliperidone palmitate depot suspension for injection (every 3 months) 175, 263, 350 and 525 mg product-specific bioequivalence guidance
Questions and answers on standard animal weights for estimating worst-case consumer exposure scenarios
Concept paper on the revision of the guideline on veterinary medicinal products controlling Varroa destructor parasitosis in bees
Human medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2024
Summary of opinion: Padcev, 25/07/2024 Positive
Summary of opinion: Edurant, 25/07/2024 Positive
Summary of opinion: Braftovi, 25/07/2024 Positive
Summary of opinion: Mektovi, 25/07/2024 Positive
Summary of opinion: Slenyto, 25/07/2024 Positive